selinexor
OSU-13124
Phase 1 small_molecule completed
Quick answer
selinexor for Recurrent Melanoma is a Phase 1 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Recurrent Melanoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed